REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 23 filers reported holding REVANCE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 24,587 | $27,677,000 | 2.71% |
| ZAZOVE ASSOCIATES LLC | 15,650,000 | $17,558,000 | 2.07% |
| Mohican Financial Management, LLC | 1,150,000 | $1,279,000 | 0.83% |
| SSI INVESTMENT MANAGEMENT LLC | 4,287,000 | $4,800,000 | 0.35% |
| DeepCurrents Investment Group LLC | 6,918,000 | $7,639,000 | 0.26% |
| Asset Allocation & Management Company, LLC | 240,000 | $269,000 | 0.13% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,362,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 3,500,000 | $3,968,000 | 0.04% |
| Citadel Advisors | 104,329,000 | $117,539,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,289,000 | 0.03% |